Among 4115 patients with ER or PgR positive and not HER2 overexpressed breast cancers, reduced cancer-free intervals were noted in patients whose tumors had lower PgR expression and higher Ki-67 value [25]. The gene discussed is ERBB2; the disease is breast carcinoma.